Skip to Main Content

Paper Details

Pharmacological inhibition of the transcription factor PU.1 in leukemia.
J Clin Invest
79
2017
AML, AML cells, DNA, PU, PU.1, acute myeloid leukemia, chromatin, heterocyclic diamidine, human, leukemia, mice, murine, patients, shRNA, target gene promoters, transcription factor PU.1, tumor
Author NameAffiliation
Il??ana Antony-Debr??Albert Einstein College of Medicine
Alberto Ambesi-ImpiombatoInstitute for Cancer Genetics, Columbia University
Evripidis Gavathiotis
Evripidis GavathiotisAlbert Einstein Cancer Center
Evripidis GavathiotisRuth L. and David S. Gottesman Institute for Stem Cell Biology and Regenerative Medicine, Albert Einstein College of Medicine
  • 1 - 5

Datasets

Release 1.2